羧化不全骨钙素与冠心病类型及其病变程度的相关性研究
[Abstract]:Objective: to investigate the relationship between serum carboxylation of incomplete osteocalcin and the type of coronary artery disease and the degree of coronary artery disease, and whether serum carboxylated incomplete osteocalcin level is an independent risk factor for coronary heart disease. Methods: 180 patients undergoing coronary angiography were selected as study objects. Collect patient history data, general data include: age, gender, diabetes history, hypertension history, smoking history, alcohol history. Laboratory data include: serum carboxylation incomplete osteocalcin, blood lipids, blood sugar and so on. Clinical parameters: systolic blood pressure, diastolic blood pressure, coronary angiography and echocardiography. According to the results of coronary angiography, 140 cases in coronary heart disease group and 40 cases in normal control group were divided into two groups. To compare the difference of clinical indexes between the two groups. According to the type of coronary heart disease, coronary heart disease group was divided into three groups: acute myocardial infarction (AMI), unstable angina pectoris (UAP), stable angina pectoris (SAP). At the same time, according to the number of vessel branches, they were divided into two groups: single vessel group and multi-vessel lesion group. The serum carboxylation incomplete osteocalcin levels were compared among each group. To investigate the correlation between serum carboxylated osteocalcin and severity of coronary artery disease according to Gensini score. Multivariate Logistic regression analysis was performed to determine whether serum carboxylation of osteocalcin was an independent risk factor for coronary heart disease (CHD). The result is 1: 1. The level of serum carboxylation incomplete osteocalcin in coronary heart disease group was significantly lower than that in non-coronary heart disease group [(1.02 卤0.35) ng/ml vs (1.32 卤0.51) ng/ml], the difference was statistically significant (P0.05) .2. Serum carboxylated osteocalcin levels in SAP group were (1.22 卤0.38) ng/ml, (1.04 卤0.23) ng/ml, (0.89 卤0.21) ng/ml., respectively. Serum carboxylation incomplete osteocalcin levels in the three groups were significantly lower than that in the non-coronary heart disease group (1.32 卤0.51) ng/ml, difference was statistically significant (P0.05) .3. The serum carboxylation incomplete osteocalcin levels were (1.32 卤0.51) ng/ml, (1.10 卤0.36) ng/ml, (0.97 卤0.34) ng/ml o in normal control group, (1.32 卤0.51) ng/ml, in single group and (0.97 卤0.34) ng/ml o in multivessel lesion group. The serum level of osteocalcin in multivessel lesion group was significantly lower than that in single vessel lesion group (P0.05). 4. Serum carboxylation incomplete osteocalcin levels were (0.96 卤0.32) ng/ml, (1.12 卤0.34) ng/ml, in Gensini high score group and (0.96 卤0.32) ng/ml, in Gensini low score group, the difference was statistically significant (P0.05). Multivariate Logistic regression analysis was performed in patients with coronary heart disease. The results showed that the low serum carboxylation incomplete osteocalcin level was an independent risk factor for coronary heart disease. Conclusion 1. The level of serum carboxylation incomplete osteocalcin was closely related to the type of coronary heart disease and the severity of coronary artery disease. Low serum carboxylation incomplete osteocalcin level is an independent risk factor for coronary heart disease and can be used for early detection of clinical coronary heart disease risk population.
【学位授予单位】:湖南师范大学
【学位级别】:硕士
【学位授予年份】:2016
【分类号】:R541.4
【相似文献】
相关期刊论文 前10条
1 郭晓梅;中老年人骨钙素含量与影响因素分析[J];中国校医;2001年02期
2 贾建成,石银华;骨钙素检测的临床应用[J];宁夏医学杂志;2002年10期
3 叶凌,李江宁,李联钦;骨钙素在体内的表达[J];国外医学.口腔医学分册;2002年04期
4 方少均,潘光成,俞莉;尿脱氧吡啶啉骨钙素评价糖尿病骨代谢异常的价值[J];浙江临床医学;2004年08期
5 马云;罗贵有;王明飞;;深圳地区2333名健康人骨钙素水平分析[J];中国临床保健杂志;2006年02期
6 江莎;侯加法;;骨钙素临床应用研究进展[J];中国骨质疏松杂志;2010年05期
7 王计艳;邢学农;;骨钙素对糖、脂代谢影响的研究进展[J];国际病理科学与临床杂志;2011年01期
8 徐勇;王锋;;骨钙素的研究进展及其与运动的联系[J];武汉商业服务学院学报;2011年06期
9 李美子;宋永坡;;骨钙素与2型糖尿病及代谢影响的研究进展[J];吉林医学;2012年14期
10 柴本甫;;骨钙素[J];国外医学.创伤与外科基本问题分册;1988年01期
相关会议论文 前10条
1 胡雪琴;糜漫天;;骨钙素及其表达调控[A];中国营养学会营养科研基金项目论文汇编之一[C];2006年
2 兰以撒;蔡景英;柳亢中;喻业安;;肺心病患者骨钙素放免测定[A];骨质疏松研究与防治文集[C];1994年
3 柯耀华;何进卫;傅文贞;章振林;;中国正常人群中骨钙素水平与糖脂代谢的研究[A];中华医学会第六次全国骨质疏松和骨矿盐疾病学术会议暨中华医学会骨质疏松和骨矿盐疾病分会成立十周年论文汇编[C];2011年
4 柯耀华;何进卫;傅文贞;章振林;;中国正常人群中骨钙素水平与糖脂代谢的研究[A];中华医学会第三次骨质疏松和骨矿盐疾病中青年学术会议论文汇编[C];2011年
5 柯耀华;何进卫;傅文贞;章振林;;中国正常人群中骨钙素水平与糖脂代谢的研究[A];中华医学会第十次全国内分泌学学术会议论文汇编[C];2011年
6 郑纯礼;任莉芬;陈尔秀;;母乳汁内骨钙素等六种生化指标的测定[A];第五届全国优生科学大会论文汇编[C];2000年
7 陈斌;徐又佳;;膜铁转运蛋白1突变斑马鱼骨形态及骨钙素变化的初步观察[A];中华医学会第七次全国骨质疏松和骨矿盐疾病学术会议论文汇编[C];2013年
8 林寰东;李小明;马慧;高鑫;;骨钙素与肝脏脂肪含量关系的研究[A];中华医学会第十二次全国内分泌学学术会议论文汇编[C];2013年
9 胡雪琴;糜漫天;王继林;张乾勇;黄国荣;毕桂苹;袁家林;于斌;;铅暴露对儿童体内钙及骨钙素的影响[A];首届中国西部营养与健康、亚健康学术会议论文集[C];2005年
10 陈凌;白洁;;糖尿病微血管病对骨密度及骨钙素的影响[A];第八届全国骨质疏松年会暨第五届全国钙剂年会会议文集[C];2002年
相关博士学位论文 前4条
1 杨超;骨钙素在睾丸间质细胞中表达及功能研究[D];哈尔滨工业大学;2014年
2 高t熡,
本文编号:2237991
本文链接:https://www.wllwen.com/yixuelunwen/xxg/2237991.html